(Q43077121)

13 November 2017

title

Therapeutic effect of pirarubicin-based chemotherapy for osteosarcoma patients with lung metastasis (English)

1 reference

13 November 2017

1 reference

Hui Zhao

1

1 reference

13 November 2017

Yang Yao

2

1 reference

13 November 2017

Zhiyu Wang

3

1 reference

13 November 2017

Feng Lin

4

1 reference

13 November 2017

Yuanjiu Sun

5

1 reference

13 November 2017

Ping Chen

6

1 reference

13 November 2017

publication date

1 April 2010

1 reference

13 November 2017

published in

Journal of Chemotherapy

1 reference

13 November 2017

volume

22

1 reference

13 November 2017

issue

2

1 reference

13 November 2017

page(s)

119-124

1 reference

Primary metastatic osteosarcoma: presentation and outcome of patients treated on neoadjuvant Cooperative Osteosarcoma Study Group protocols

13 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2010.22.2.119

Phase II trial of 4'-0-tetrahydropyranyladriamycin (pirarubicin) in head and neck carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2010.22.2.119

A phase II study of a THP-COP regimen for the treatment of elderly patients aged 70 years or older with diffuse large B-cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2010.22.2.119

Apoptosis in young rats with adriamycin-induced cardiomyopathy--comparison with pirarubicin, a new anthracycline derivative

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2010.22.2.119

Pirarubicin-based versus doxorubicin-based osteosarcoma chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2010.22.2.119

Strategies for targeting the multidrug resistance-1 (MDR1)/P-gp transporter in human malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2010.22.2.119

Serial topoisomerase II expression in primary breast cancer and response to neoadjuvant anthracycline-based chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2010.22.2.119

Relationships between the in vitro cytotoxicity and transport characteristics of pirarubicin and doxorubicin in M5076 ovarian sarcoma cells, and comparison with those in Ehrlich ascites carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2010.22.2.119

10.1179/JOC.2010.22.2.119

21 January 2018

Identifiers

DOI

1 reference

13 November 2017

1 reference